Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability of GnRH Analogue Administration in Advanced Prostate Cancer
NCT01161563Phase 4Completed
- Sponsor
- Watson Pharmaceuticals
- Start
- Jul 2010
- Primary completion
- Apr 2011
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of triptorelin pamoate in prostate cancer (PCa), sponsored by Watson Pharmaceuticals. Started Jul 2010; status: completed.
02
Drugs
triptorelin pamoate
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01161563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01161563.